[1. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377:63-73. DOI: 10.1016/S0140-6736(10)61266-410.1016/S0140-6736(10)61266-4]Search in Google Scholar
[2. Vohra P, Poxton IR. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology. 2011;157:1343-53. DOI: 10.1099/mic.0.046243-010.1099/mic.0.046243-021330434]Search in Google Scholar
[3. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47:1162-70. DOI: 10.1086/59225710.1086/59225718808358]Search in Google Scholar
[4. Stabler RA, He M, Dawson LFT, Martin M, Valiente E, Parkhill J, et al Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 2009;10:R102. DOI: 10.1186/gb-2009-10-9-r10210.1186/gb-2009-10-9-r102276897719781061]Search in Google Scholar
[5. Lim SK, Stuart RL, Mackin KE, Carter GP, Kotsanas D, Francis MJ, et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis. 2014;58:1723-30. DOI: 10.1093/cid/ciu20310.1093/cid/ciu20324704722]Search in Google Scholar
[6. Rafila A, Indra A, Popescu GA, Wewalka G, Allerberger F, Benea S, et al. Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania. J Infect Dev Ctries. 2014;8:694-8. DOI: 10.3855/jidc.443510.3855/jidc.443524916866]Search in Google Scholar
[7. Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis –based PCR ribotyping. J Med Microbiol. 2008;57:1377-82. DOI: 10.1099/jmm.0.47714-010.1099/jmm.0.47714-0288493818927415]Search in Google Scholar
[8. van den Berg RJ, Claas ECJ, Oyib DH, Klaassen CHW, Dijkshoorn L, Brazier JS, et al. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol. 2004;42:1035–41. DOI: 10.1128/JCM.42.3.1035-1041.200410.1128/JCM.42.3.1035-1041.200435689815004050]Search in Google Scholar
[9. Kato N, Ou CY, Kato H, Bartley SL, Brown VK, Dowell VRJ, Jr, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol. 1991;29:33–7.10.1128/jcm.29.1.33-37.19912696971993763]Search in Google Scholar
[10. Kato H, Kato N, Katow S, Maegawa T, Nakamura S, Lyerly DM. Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett. 1999;175:197–203. DOI: 10.1111/j.1574-6968.1999. tb13620.x]Search in Google Scholar
[11. Stubbs SL, Brazier JS, Talbot PR, Duerden BI. PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes. J Clin Microbiol. 2000;38:3209–13.10.1128/JCM.38.9.3209-3213.20008735810970359]Search in Google Scholar
[12. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol. 2002;40:3470–5. DOI: 10.1128/JCM.40.9.3470-3475.200210.1128/JCM.40.9.3470-3475.200213071612202595]Search in Google Scholar
[13. Curry SR, Marsh JW, Muto CA, O’Leary MM, Pasculle AW, Harrison LH. tcdC Genotypes associated with severe tcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol. 2007;45:215–21. DOI: 10.1128/JCM.01599-0610.1128/JCM.01599-06182895917035492]Search in Google Scholar
[14. Wolff D, Brüning T, Gerritzen A. Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis. Eur J Clin Microbiol Infect Dis. 2009;28:959-62. DOI: 10.1007/s10096-009-0731-710.1007/s10096-009-0731-719333630]Search in Google Scholar
[15. Ecker DJ, Sampath R, Blyn LB, Eshoo MW, Ivy C, Ecker JA, et al. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc Natl Acad Sci U S A. 2005;102:8012-7. DOI: 10.1073/pnas.040992010210.1073/pnas.0409920102113825715911764]Search in Google Scholar
[16. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn. 2012;14:295-304. DOI: 10.1016/j.jmoldx.2012.02.00510.1016/j.jmoldx.2012.02.005710602722584138]Search in Google Scholar
[17. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012;55:1056-63. DOI: 10.1093/cid/cis61410.1093/cid/cis61422784871]Search in Google Scholar
[18. Popescu G, Serban R, Pistol A, Niculcea A, Preda A, Lemeni D, et al. Clinical and microbiological characterization of Clostridium difficile infection in Romania (2013-2014); a hospital-based study, BMC Infect Dis. 2014;14(Suppl 7):O24. DOI: 10.1186/1471-2334-14-S7-O2410.1186/1471-2334-14-S7-O24]Search in Google Scholar
[19. Drudy D, Fanning S, Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis. 2007;11:5–10. DOI: 10.1016/j.ijid.2006.04.00310.1016/j.ijid.2006.04.00316857405]Search in Google Scholar